Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

SONN Sonnet BioTherapeutics Holdings Inc

1,24

-0,0143 (-1,14%)

11 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Sonnet BioTherapeutics Charts.

News Sonnet BioTherapeutics Holdings Inc

Form 8-K - Current report
Freitag 4 April 2025 (7 Tage vor) • Edgar (US Regulatory)

Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose
Freitag 4 April 2025 (7 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 1 April 2025 (1 Woche vor) • Edgar (US Regulatory)

Sonnet Announces Release of Corporate Update Video
Dienstag 1 April 2025 (1 Woche vor) • GlobeNewswire Inc.

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
Dienstag 1 April 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 26 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
Mittwoch 26 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 19 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein
Mittwoch 19 März 2025 (3 Wochen vor) • GlobeNewswire Inc.

Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Dienstag 11 März 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 26 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 21 Februar 2025 (2 Monate vor) • Edgar (US Regulatory)

Weitere Sonnet BioTherapeutics Holdings Inc News-Artikel

JP Morgan Chase

Financial Select Sector

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen